Global Smart Biopsy Devices Market Report 2024: Growth Rate, Major Segments And Regions

According to a new market research report Biopsy Devices Market by Product (Core Needle Biopsy, Aspiration Biopsy, Vacuum Assisted Biopsy) Application (Breast Biopsy, Lung Biopsy, Prostate Biopsy) Guidance (Stereotactic, Ultrasound) & by End User (Hospital) - Global Forecast to 2022, published by MarketsandMarkets™, the market is expected to reach USD 2.42 Billion by 2022 from an estimated USD 1.74 Billion in 2017, at a CAGR of 6.8% during the forecast period.Browse 180 Market Data Tables and 42 Figures spread through 219 Pages and in-depth TOC on "Biopsy Devices Market"Download PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=132886515 The Report analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.Factors such as rising prevalence of cancer, increasing preference for minimally invasive surgeries, and initiatives undertaken by governments & global health organizations are the major factors driving the growth of this market.By product, the needle-based biopsy instruments segment accounted for the largest share of the marketOn the basis of product, the needle-based biopsy instruments segment accounted for the largest share of the global biopsy devices market in 2016.

This can be attributed to the preference of needle-based biopsies over open surgical biopsies and increasing preference for minimally invasive surgeries.The lung biopsy segment is expected to highest growth during the forecast periodBased on application, the lung biopsy segment accounted for the largest share of the biopsy devices market.

Additionally, the availability of funding for lung cancer research is contributing to the growth of this market segment.The ultrasound-guided biopsy segment dominated the market in 2016Based on guidance technique, the ultrasound-guided biopsy segment accounted for the largest share of the biopsy devices market.

This quick and simple procedure offers advantages, such as no ionizing radiation exposure, low complication rate, and lower cost as compared to other biopsy techniques.The hospitals segment held the highest CAGR during the forecast periodBased on end user, the hospitals segment is expected to register the highest growth rate during the forecast period.

The strong financial capabilities of hospitals and the presence of trained professionals are the major factors supporting the rising adoption of biopsy devices among hospitals.North America dominated the market in 2016North America accounted for the largest share of the biopsy devices market in 2016, followed by Europe.

The rising prevalence of cancer, government initiatives to spread awareness about cancer, favorable reimbursement scenario for biopsy devices in the U.S., and the presence of key players in the region are the key factors driving the growth of the biopsy devices market in North America.Request For Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=132886515 The major players in the biopsy devices market are C. R. Bard, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Cook Group Incorporated (U.S.), Devicor Medical Products, Inc., (Leica Biosystems) (Germany), Argon Medical Devices (U.S.), B. Braun Melsungen AG (Germany), Cardinal Health, Inc. (U.S.), Olympus Corporation (Japan), Boston Scientific Corporation (U.S.), FUJIFILM Holdings Corporation (Japan), INRAD, Inc. (U.S.), and Medtronic plc (Ireland).About MarketsandMarkets™MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues.

Industry InsightsThe global Biopsy Devices Market size is estimated to reach USD 2.3 billion by 2020, exhibiting a 6.4% CAGR during the forecast period.

Growing incidence of cancer and rising demand pertaining to patient’s unmet need for accurate diagnosis is expected to drive the market forward in the coming years.Rising income levels and growing modern healthcare infrastructure has increased the life expectancy considerably.

Aforementioned factors are anticipated to propel progress in this market.Rising cancer incidence is anticipated to drive the demand for this technology thus leading to substantial growth over the forecast period.

As per American Cancer Society, by the end of 2030, the global cancer burden is estimated to reach 21.7 million with respect to number of cases and reach 13 million cancer deaths.Advantages associated with the use of these procedures include less invasiveness and fast recovery as compared to the conventional approaches.

As a consequence of increase in demand for procuring internal organ samples from soft tissue sources such as prostate gland, kidneys, bone marrow, and breast tissues this segment is anticipated to witness fastest growth.Technological innovations drive the progress rate of the market.

For instance, Aspirational syringe gun developed by INRAD Inc. is gaining huge popularity due to the novel technology incorporated in the same.

The latest trending report Global Prostate Biopsy Devices Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 offered by DecisionDatabases.com is an informative study covering the market with detailed analysis.

The report will assist reader with better understanding and decision making.The global Prostate Biopsy Devices market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.3% in the forecast period of 2020 to 2025 and will expected to reach USD 688 million by 2025, from USD 560.4 million in 2019.The Prostate Biopsy Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.Browse the complete report and table of contents @ https://www.decisiondatabases.com/ip/16784-prostate-biopsy-devices-market-analysis-reportMarket segmentationProstate Biopsy Devices market is split by Type and by Application.

For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value.

This analysis can help you expand your business by targeting qualified niche markets.By Type, Prostate Biopsy Devices market has been segmented into Reusable Devices, Disposable Devices, etc.By Application, Prostate Biopsy Devices has been segmented into Hospitals, Ambulatory Surgical Center (ASCs), Diagnostic Centers, etc.Regions and Countries Level AnalysisRegional analysis is another highly comprehensive part of the research and analysis study of the global Prostate Biopsy Devices market presented in the report.

For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Prostate Biopsy Devices market.The report offers in-depth assessment of the growth and other aspects of the Prostate Biopsy Devices market in important countries (regions), including United States, Canada, Mexico, Germany, France, United Kingdom, Russia, Italy, China, Japan, Korea, India, Southeast Asia, Australia, Brazil and Saudi Arabia, etc.

It also throws light on the progress of key regional Prostate Biopsy Devices markets such as North America, Europe, Asia-Pacific, South America and Middle East & Africa.Competitive Landscape and Prostate Biopsy Devices Market Share AnalysisProstate Biopsy Devices competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Prostate Biopsy Devices sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch.

The Global Biopsy Devices Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026 gives an evaluation of the market developments based on historical studies and comprehensive research respectively.

The market segments are also provided with an in-depth outlook of the competitive landscape and a listing of the profiled key players.The comprehensive value chain analysis of the market will assist in attaining better product differentiation, along with detailed understanding of the core competency of each activity involved.

The market attractiveness analysis provided in the report aptly measures the potential value of the market providing business strategists with the latest growth opportunities.The report classifies the market into different segments based on product.

These segments are studied in detail incorporating the market estimates and forecasts at regional and country level.

The segment analysis is useful in understanding the growth areas and probable opportunities of the market.Final Report will cover the impact of COVID-19 on this industry.Browse the complete Global Biopsy Devices Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026 @ https://www.decisiondatabases.com/ip/16371-biopsy-devices-market-reportThe report also covers the complete competitive landscape of the global Biopsy Devices market with company profiles of key players such as:AngiotechCardinal Health IncCarefusion CorporationC.

R. BARD, IncDevicor Medical Products Inc.DTR MedicalHologic, IncINRAD, IncUK BiopsyA detailed description of each has been included, with information in terms of H.Q, future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other latest industrial developments.SEGMENTATIONS IN THE REPORT:By Product:Needle-based Biopsy GunsVacuum-assisted Biopsy (VAB) DevicesFine Needle Aspiration Biopsy (FNAB) DevicesCore Needle Biopsy (CNB) devicesBiopsy Guidance SystemsManualRoboticBiopsy NeedlesDisposableReusableBiopsy ForcepsGeneral Biopsy ForcepsHot Biopsy ForcepsOthersBrushesCurettesPunchesBy Geography:North America (NA)Europe (EU)Asia Pacific (APAC)Rest of the World (RoW)Download Free Sample Report of Global Biopsy Devices Market @ https://www.decisiondatabases.com/contact/download-sample-16371The Global Biopsy Devices Market has been exhibited in detail in the following chapters –Chapter 1 Biopsy Devices Market PrefaceChapter 2 Executive SummaryChapter 3 Biopsy Devices Industry AnalysisChapter 4 Biopsy Devices Market Value Chain AnalysisChapter 5 Biopsy Devices Market Analysis By ProductChapter 6 Biopsy Devices Market Analysis By GeographyChapter 7 Competitive Landscape Of Biopsy Devices CompaniesChapter 8 Company Profiles Of Biopsy Devices IndustryPurchase the complete Global Biopsy Devices Market Research Report @ https://www.decisiondatabases.com/contact/buy-now-16371Other Reports by DecisionDatabases.com:Global Liquid Biopsy Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026Global Anesthesia Monitoring Devices Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026Global Neurostimulation Devices Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026About-Us:DecisionDatabases.com is a global business research reports provider, enriching decision makers and strategists with qualitative statistics.

The global Smart Biopsy Devices Market is expected to exhibit a CAGR of 9.4% over the forecast period from 2017 to 2023, according to a new report from Market Research Future (MRFR).

The report also compiles an extended analysis on the market’s key drivers as well as the key restraints likely to hold back the market over the forecast period.The global skin biopsy market is mainly driven by the growing prevalence of skin cancer and the utilization of skin biopsy in skin cancer diagnosis.

The growing awareness about skin cancer in emerging regions is likely to be a major driver for the global skin biopsy market, as it has become increasingly easier to diagnose and treat skin cancer in developing regions in the last few years with the growing availability of advanced medical facilities.

Based on indication, the market for skin biopsy has been segmented into actinic keratosis, cancer, dermatitis, psoriasis, skin infection, and others.

The skin infection segment is sub-segmented into basal cell carcinoma, deep fungal infections, melanoma, squamous cell carcinoma, and viral infections.

According to the American Academy of Dermatology, one in four American is affected by skin disease of some kind.